Ainos, Inc. (NASDAQ:AIMD) Short Interest Up 107.8% in December

Ainos, Inc. (NASDAQ:AIMD) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 23,172 shares, an increase of 107.8% from the November 30th total of 11,153 shares. Currently, 0.5% of the company’s shares are short sold. Based on an average daily trading volume, of 31,273 shares, the days-to-cover ratio is currently 0.7 days. Based on an average daily trading volume, of 31,273 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.5% of the company’s shares are short sold.

Insider Buying and Selling at Ainos

In other news, major shareholder Carbon Nano Technology Taiwan sold 7,000 shares of the firm’s stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $3.59, for a total value of $25,130.00. Following the completion of the sale, the insider directly owned 1,037,206 shares in the company, valued at $3,723,569.54. This trade represents a 0.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 9.79% of the company’s stock.

Institutional Trading of Ainos

An institutional investor recently bought a new position in Ainos stock. Two Sigma Investments LP bought a new stake in shares of Ainos, Inc. (NASDAQ:AIMD) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned about 0.48% of Ainos at the end of the most recent quarter.

Ainos Stock Performance

NASDAQ:AIMD opened at $1.95 on Friday. The company has a market capitalization of $9.40 million, a price-to-earnings ratio of -0.49 and a beta of 2.39. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.96 and a quick ratio of 2.67. Ainos has a 1-year low of $1.78 and a 1-year high of $5.00. The business has a 50 day moving average of $2.57 and a 200 day moving average of $3.01.

Ainos (NASDAQ:AIMD) last released its earnings results on Thursday, November 13th. The company reported ($0.64) earnings per share for the quarter. The firm had revenue of $0.00 million during the quarter.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Wall Street Zen upgraded Ainos from a “sell” rating to a “hold” rating in a research note on Friday, September 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ainos in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.